Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol.
D000293:Adolescent; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy* / Q000378:metabolism; D000324:Adrenocorticotropic Hormone; D000328:Adult; D000450:Aldosterone / Q000031:analogs & derivatives / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D004573:Electrolytes / Q000378:metabolism; D005260:Female; D005438:Fludrocortisone / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D006908:Hydroxyprogesterones / Q000097:blood*; D008297:Male; D011627:Puberty; D012083:Renin / Q000097:blood*
D004573:Electrolytes; D006908:Hydroxyprogesterones; D000450:Aldosterone; D000324:Adrenocorticotropic Hormone; D012083:Renin; D005438:Fludrocortisone; D006854:Hydrocortisone